Denardo Dunham
Foot Surgery · New Orleans, LANPI 1609836055
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,337 of the $5,165 with a category attached, or 64.6%. It is spread thinly across 11 manufacturers, the largest accounting for just 23.4%. Reporting peaked in 2019 at $2,601 and has fallen 99.0% since, to $25 in 2025.
Across 83 payments — averaging $62.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$1K
- Arthrosurface Incorporated$1K
- Organogenesis Inc.$654
- Crossroads Extremity Systems, LLC$643
- Stryker$631
- Smith+Nephew$586
- plus $398 from 5 others
What the payments were for
- Consulting fees$1002%
- Travel & lodging$1,72733%
- Food & beverage$3,33765%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 10 | $1,211 |
| Arthrosurface Incorporated | 9 | $1,041 |
| Organogenesis Inc. | 9 | $654 |
| Crossroads Extremity Systems, LLC | 6 | $643 |
| Stryker(2 entities) | 17 | $631 |
| Smith+Nephew | 23 | $586 |
| Zimmer Biomet | 5 | $208 |
| Comsort, Inc | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $57 |
| Sanara Medtech Inc. | 1 | $24 |
| Fusion Orthopedics USA, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemiCAP MTP Resurfacing$821
- Lapiplasty System$768
- Apligraf$248
- Dermagraft$248
- Puraply/Affinity/NuTech$248
- PuraPly$212
- Grafix$143
- Oasis$143
- REGRANEX$122
- ANCHORAGE$109
- SIVEXTRO$100
How this compares
Too few foot surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 93 | $2,001 |
| Diclofenac Sodium | 47 | $1,394 |
| Clobetasol Propionate | 17 | $1,302 |
| Lidocaine | 29 | $1,241 |
| Ketoconazole | 36 | $840 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 18 | $243 |
| Meloxicam | 37 | $68 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in New Orleans
- Chantal LorioNew Orleans$185
- Maria MarkiewiczMetairie$8K
- Maria SaucierAlexandria$7K
- Marc GlovinskyMetairie$7K
- Darren VigeeLacombe$5K
- Robert KadishMetairie$4K
- Gregory BryanShreveport$4K
- Richard DrummondShreveport$3K
- Laurence WelkerShreveport$2K
- Frederick HallShreveport$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.